Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FPLAR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,857
Award facts
- Contract value 100% obligated
- $13,857.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,857.23 to AmerisourceBergen Drug Corp for GARDASIL 9 syringes (0.5mL) under a firm fixed-price contract. The award, issued on August 26, 2025, with completion scheduled for August 27, 2025, represents a routine pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award involved no set-aside designation, indicating it was competitively awarded through the standard procurement process.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply chains, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA covering a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic areas. This delivery order for GARDASIL 9, a human papillomavirus vaccine, reflects the company's role in supplying essential immunization products to support Department of Defense medical operations and military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB25FPLAR?
SPE2DB25FPLAR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FPLAR worth?
The government has obligated $13,857 on SPE2DB25FPLAR.
Is contract SPE2DB25FPLAR an order under another contract?
Yes. SPE2DB25FPLAR is a delivery order under SPE2DB25D3109, an indefinite delivery contract.
Was contract SPE2DB25FPLAR competed?
The extent of competition for SPE2DB25FPLAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award